brexanolone

Rapid-Acting Pill to Treat Postpartum Depression is Approved
On August 4th, the U.S. Food and Drug Administration (FDA) approved zuranolone, the first oral medication designed to treat postpartum depression (PPD) in adults. The drug, which is rapid-acting, was… Read More